Amundi Asset Management US’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-281
Closed -$10K 1564
2020
Q3
$10K Hold
281
﹤0.01% 1523
2020
Q2
$11K Hold
281
﹤0.01% 1532
2020
Q1
$10K Sell
281
-6,050
-96% -$235K ﹤0.01% 1528
2019
Q4
$256K Hold
6,331
﹤0.01% 1421
2019
Q3
$220K Buy
6,331
+2,286
+57% +$75.3K ﹤0.01% 1438
2019
Q2
$128K Buy
+4,045
New +$120K ﹤0.01% 1545

Other funds holding PBH

Amundi Asset Management US's PBH Position: Q4 2020 in Review

Amundi Asset Management US sold out of Prestige Consumer Healthcare (PBH) in Q4 2020, closing a stake of 281 shares — an estimated $10K sold.

Amundi Asset Management US first reported a position in PBH in Q2 2019 and held it in 6 quarters. The position peaked at $256K in Q4 2019. 237 funds tracked by Wall St. Rank hold PBH as of Q4 2020.

  • Amundi Asset Management US reported no remaining Prestige Consumer Healthcare position as of Q4 2020 after selling out during the quarter.
  • Amundi Asset Management US sold 281 Prestige Consumer Healthcare shares in Q4 2020, an estimated $10K.
  • Amundi Asset Management US first reported a position in Prestige Consumer Healthcare in Q2 2019 and held it in 6 quarters.
  • Amundi Asset Management US's Prestige Consumer Healthcare position peaked at $256K in Q4 2019.
  • 237 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2020.

Based on Amundi Asset Management US's 13F filing for Q4 2020, filed 16 Feb 2021.